Personalized Genomics Market Opportunities Are Emerging Beyond Traditional Growth Areas
Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Personalized Genomics Market Growth Potential: How Will Market Size Change Through 2030?
The personalized genomics market has experienced significant expansion in recent years, with the sector projected to increase from $9.45 billion in 2025 to $10.96 billion in 2026, reflecting a compound annual growth rate (CAGR) of 16.0%. This historical growth has been largely driven by factors such as the decreasing expenses associated with genetic sequencing, a rising incidence of chronic and genetic disorders, enhanced research activities in genomics, the development and broadening of diagnostic laboratory facilities, and the early implementation of precision medicine strategies.
The personalized genomics market is projected to experience rapid expansion over the coming years. By 2030, it is expected to reach $19.61 billion, driven by a compound annual growth rate (CAGR) of 15.7%. Growth during this forecast period is fueled by the integration of genomics into standard clinical practices, an increasing need for tailored medical treatments, improvements in sequencing technologies, the broadening of wellness and ancestry testing services, and heightened investments from pharmaceutical and biotechnology firms. Key trends for this period encompass the growing popularity of direct-to-consumer genetic testing, the wider application of pharmacogenomics in designing treatment plans, a rising emphasis on preventive and predictive healthcare, the expansion of genetic testing within reproductive health, and greater public awareness regarding lifestyle and wellness genomics.
Download A Free Sample Report For Comprehensive Market Insights:
#Personalized Genomics Market Growth Factors: Which Forces Are Supporting Market Expansion?
The growing incidence of chronic conditions is anticipated to accelerate the expansion of the personalized genomics market moving forward. Chronic diseases are enduring health issues that necessitate ongoing care and include ailments such as diabetes, heart disease, hypertension, and various other complex medical problems. This uptick in chronic illnesses is mainly driven by aging populations, inactive lifestyles, poor eating habits, and environmental influences, which often result in the simultaneous occurrence of multiple conditions. Personalized genomics aids in managing chronic diseases by facilitating large-scale genotyping and sequencing to categorize patients according to genetic susceptibility, thus enabling more accurate diagnostics, targeted therapies, and improved preventive approaches. For example, in April 2025, the U.S. Centers for Disease Control and Prevention (CDC), an American agency, reported that 76.4% of U.S. adults—roughly 194 million individuals—had at least one of twelve specific chronic conditions, and 51.4% (around 130 million) had two or more of these conditions. Consequently, the rising prevalence of chronic diseases is fueling the growth of the personalized genomics market.
Personalized Genomics Market Segmentation And Category Breakdown
The personalized genomics market covered in this report is segmented –
1) By Test Type: Oncology Testing, Neurological Testing, Cardiovascular Testing, Other Test Types
2) By Technology: Polymerase Chain Reaction-Based Tests, Microarray-Based Tests, Sequencing-Based Tests, Other Technologies
3) By Application: Diagnostics, Precision Medicine, Wellness, Reproductive Health, Sports Nutrition And Health, Lifestyle, Other Applications
4) By End User: Hospitals And Clinics, Research Centers, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Other End Users
Subsegments:
1) By Oncology Testing: Liquid Biopsy, Tumor Profiling, Genetic Testing For Cancer Risk, Companion Diagnostics
2) By Neurological Testing: Alzheimer’s Disease Testing, Huntington’s Disease Testing, Parkinson’s Disease Testing, Epilepsy Testing
3) By Cardiovascular Testing: Genetic Risk for Cardiovascular Diseases, Arrhythmia Testing, Coronary Artery Disease Testing
4) By Other Test Types: Pharmacogenomics Testing, Genetic Screening For Inherited Disorders, Ancestry Testing
Personalized Genomics Market Industry Trends: What Changes Are Reshaping Demand?
Leading industry players in the personalized genomics sector are prioritizing the development of advanced technologies, including personalized genomics platforms, designed to deliver customized insights into health, wellness, and disease avoidance. A personalized genomics platform functions by examining an individual’s genetic information to produce specific recommendations and perspectives concerning health, well-being, and illness susceptibility. As an example, in September 2024, Neuberg Diagnostics Private Limited, a diagnostic service provider headquartered in India, launched Geniee Decode Your DNA, an innovative personalized genomics platform. This system offers individualized guidance on health, nutrition, and medication derived from your genetic profile, aiding in the optimization of wellness, the prevention of diseases, and the customization of treatments for superior health outcomes.
Personalized Genomics Market Competitive Analysis Of Major Industry Participants
Major companies operating in the personalized genomics market are Thermo Fisher Scientific Inc., Illumina Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Invitae Corporation, Guardant Health Inc., GeneDx LLC, Ancestry Inc., Oxford Nanopore Technologies plc, Genomic Health Inc., 23andMe Holding Co., Color Health Inc., Helix OpCo LLC, Personalis Inc., Dante Genomics, Gene By Gene Ltd., Veritas Genetics Inc., Futura Genetics, Nebula Genomics Inc., Pathway Genomics Corporation
Access The Complete Personalized Genomics Market Report:
Personalized Genomics Market Geographic Distribution And Regional Opportunities
North America was the largest region in the personalized genomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized genomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
